Waardenburg's Syndrome and Familial Periodic Paralysis C

Total Page:16

File Type:pdf, Size:1020Kb

Waardenburg's Syndrome and Familial Periodic Paralysis C Postgraduate Medical Journal (June 1971) 47, 354-360. Postgrad Med J: first published as 10.1136/pgmj.47.548.354 on 1 June 1971. Downloaded from CLINICAL REVIEW Waardenburg's syndrome and familial periodic paralysis C. H. TAY A.M., M.B., B.S., M.R.C.P.(Glas.) Senior Medical Registrar and Clinical Teacher, Medical Unit II, Department of Clinical Medicine, University of Singapore, Outram Road General Hospital, Singapore, 3 Summary McKenzie, 1958; Fisch, 1959; Arnvig, 1958; Nine members in three generations of a Chinese Partington, 1959; Di George, Olmsted & Harley, family were found to have Waardenburg's syndrome 1960; Campbell, Campbell & Swift, 1962; Chew, comprising, mainly, lateral displacement of the inner Chen & Tan, 1968). canthi, broadening of the nasal root and hyper- It is also known as a variant of the first arch trichosis of the eyebrows. Other minor features were syndrome (McKenzie, 1958; Campbell et al., 1962) also found. and later other minor characteristics of the syndrome Two patients had in addition, hypokalemic periodic were added: (1) abnormal depigmentation of the paralysis of the familial type, one had prominent skin (Klein, 1950; Mende, 1926; Partington, 1959; frontal bossing and another, bilateral cleft lips and Campbell et al, 1962), (2) pigmentary changes of the palate. These associated anomalies have not been fundi (Waardenburg, 1951; Di George et al., 1960)Protected by copyright. previously documented and the presence of two auto- and (3) abnormal facial appearance to maldevelop- somal dominant genetic defects in this family is of ment of the maxilla and mandible (Fisch, 1959; particular interest. Campbell et al., 1962). In this paper, nine members in three generations of Introduction one Chinese family were found to have Waarden- In 1951, Waardenburg described a rare hereditary burg's syndrome. The interesting aspect of this disease characterized by the following features: family is the presence of hypokalemic periodic (1) lateral displacement of the inner canthi with paralysis in two patients, frontal bossing in one and dystopia canthrum, (2) broad nasal root, (3) con- bilateral cleft lips and palate in another. None of fluent eyebrows with hypertrichosis of the medial these congenital anomalies has been previously ends, (4) heterochromia irides, (5) congenital deaf- documented. The association with familial periodic ness, (6) white forelock and (7) an autosomal domi- paralysis is of particular genetic interest, since the nant inheritance with variable penetrance. latter is also an autosomal dominant disease. http://pmj.bmj.com/ Many complete and incomplete forms of this syndrome have been reported since the original Case reports description (Keizer, 1952; Wildervanck, 1957; Case 1 (Fig. 1; II, 1 arrowed) (5 70 63 (CaseI 2),-I on September 30, 2021 by guest. 3I (j1 429 (& 27 425 ( 21 ;17 5 13 Patient 11(4 S 11,6 II. 11(2 (C as3 L5 (Case I) (Case3) (ase 4) (Case 5) (Case 6) (Case 7) m 2 ? Periodic paralysis with Waardenburgs syndrome 0 T Waardenburg's syndrome only II,1 I11.2 (Case 8) (Case 9) dc 4 Unaffected FIG.r1. The family tree. Clinical review 355 Postgrad Med J: first published as 10.1136/pgmj.47.548.354 on 1 June 1971. Downloaded from The propositus, a 27-year-old Chinese housewife, Serum potassium on admission was 1 8 mEq/l, was admitted on 3 February 1970 when she suddenly sodium 139 mEq/l and chloride 113 mEq/l. ECG: became paralysed of all four limbs early that prolonged PR and QT intervals and prominent U morning. Her speech, swallowing, breathing and waves, consistent with hypokalemia. sphincteric functions were not affected. There was The patient was treated with oral potassium no previous similar attack. She gave no history of chloride 3-6 g daily in divided doses and the motor vomiting, diarrhoea or excessive sweating and she power of her limbs rapidly returned to normal. denied taking any purgatives or drugs. Her general Serum potassium on the third day was 3-6 mEq/l, health had always been good. sodium 136 mEq/l and chloride 120 mEq/l. ECG was Examination revealed a healthy adult with no now normal. evidence of dehydration, wasting or stunting. The After discharge, she defaulted as she was staying thyroid was palpable but there were no signs of a long distance away from the clinic. When she toxicity. The pulse was 86/min, regular and of full exhausted the supply of potassium tablets, she began volume, BP 110/80 mmHg. No abnormalities were to experience periodic weakness of her limbs. At detected in the heart, lungs or abdomen. All four first, these attacks were mild and readily aborted by limbs, including the neck, were flaccid, and the drinking orange and other fruit juices, but later, the motor power, with the exception of that of the face, paralysis was severe and she was readmitted in was markedly diminished. Sensory functions re- March 1970. Serum potassium was found to be 2-1 mained intact. All the deep tendon reflexes were mEq/l and the serum sodium and chloride were reduced. The plantar responses were equivocal. normal. Again she improved with oral potassium Incidental findings in this patient were: (1) in- supplements. Since then she has been on main- creased intercanthal distance, 46 mm (normal tenance dose of potassium chloride 1 g thrice a day Chinese adults-37-40 mm (Chew et al., 1968); and remained symptom-free. The family tree of the Protected by copyright. there was also lateral displacement of lacrimal patient was traced (Fig. 1) revealing eight more punctae. The interpupillary distance was normal (65 members in three generations with similar physical mm) (normal adult range-54-75 mm), (2) broaden- abnormalities. One brother (Case 5) also had periodic ing of nasal root, (3) hyperplasia of medial end of weakness of the limbs for about 6 months. The eyebrows, (4) heterochromia of the left iris and (5) a significant features of this family are summarized in spray of white forelock (which she often concealed Table 1. by combing) (Fig. 2). There was no deafness, con- firmed by the audiogram, and no skin, fundal or Case 2 (Fig. 1; I, 1) skeletal changes. The following laboratory studies were within normal limits: complete blood count, This 70-year-old male, father of the propositus, complete urinalysis, ESR, blood urea nitrogen, basal had been in excellent health. At a very young age, metabolic rate, 1311-labelled triiodothyronine up- he migrated to Singapore from China and could not take, plasma PB 131I, thyroid antibodies (tanned red recall any disease present in his family. When seen, cell method), bilateral audiograms, X-rays of the he had grey hair and was partially deaf because of http://pmj.bmj.com/ skull, chest and abdomen, intravenous pyelograms, his old age. The intercanthal distance was increased chromosome karyotypes and urinary electrolyte to 50 mm but the interpupillary measurement was excretions. normal (66 mm). There was broadening of the nasal root and confluent eyebrows with hypertrichosis of the medial ends. No ocular, fundal or skin changes were present and he gave no history of periodic weakness. His hearing had been good until the last 5 years. on September 30, 2021 by guest. Case 3 (Fig. 1; II, 2) This 25-year-old Chinese girl, sister of the pro- positus, had no deafness or weakness of the limbs, and she had been enjoying good health. She was also found to have an increase in the intercanthal distance (43 mm) with lateral displacement of the lacrimal points, but with a normal interpupillary measurement. Her nasal root was FIG. 2. Case 1 showing lateral displacement of inner somewhat promi- canthi, broad nasal root, confluent eyebrows with hyper- nent and there was marked hypertrichosis of the eye- trichosis of the medial ends, and unilateral left hetero- brows (Fig. 3). There were no eye, skin, hair or chromia irides. auditory lesions. 356 Clinical review Postgrad Med J: first published as 10.1136/pgmj.47.548.354 on 1 June 1971. Downloaded from TABLE 1. Case 1 2 3 4 5 6 7 8 9 Generation II,1 I,1 11,2 II,3 11,4 11,5 11,6 111,1 111,2 Relationship to proband Proband Father Sister Brother Brother Brother Brother D aughter Daughter Sex/age F/27 M/70 F/25 M/21 M/17 M/15 M/13 F/3 F/2 months Lateral displacement of inner canthi and dystopia canthrum + + + + + + + + + Broad nasal root + ± + + + + + + + Hypertrichosis of eyebrows + + + + + + + + + Heterochromia ofiris + - + Congenital deafness - - - + White forelock + - - Premature hair greying + Frontal bossing + Cleft lips and palate - - - + Skin/fundus changes Periodic paralysis + - + Case 4 (Fig. 1: 11. 3) and cramps of the legs for about 6 months. These This 21-year-old Chinese man, brother of the attacks were more frequent in the mornings and propositus, gave no history of periodic paralysis, after exercise. Relief of the weakness could some- deafness or skin diseases. His intercanthal distance times be obtained by drinking soft drinks like Coca-Protected by copyright. was 41 mm and interpupillary measurement was Cola. He had no systemic disorders, but recently, normal (65 mm). There was some thickening of his some of his scalp hair had suddenly become prema- eyebrows and his nasal root was broad (Fig. 4). No turely grey. There were no skin, eye or auditory de- other abnormalities were found. fects. His intercanthal distance was increased (44 mm) but the interpupillary distance was normal (56 Case 5 (Fig. 1; II, 4) mm). There was also broadening of his nasal root This 17-year-old Chinese schoolboy, younger and confluence of the brows with hypertrichosis of brother of the propositus, had had periodic weakness the medial portions (Fig.
Recommended publications
  • Blueprint Genetics Craniosynostosis Panel
    Craniosynostosis Panel Test code: MA2901 Is a 38 gene panel that includes assessment of non-coding variants. Is ideal for patients with craniosynostosis. About Craniosynostosis Craniosynostosis is defined as the premature fusion of one or more cranial sutures leading to secondary distortion of skull shape. It may result from a primary defect of ossification (primary craniosynostosis) or, more commonly, from a failure of brain growth (secondary craniosynostosis). Premature closure of the sutures (fibrous joints) causes the pressure inside of the head to increase and the skull or facial bones to change from a normal, symmetrical appearance resulting in skull deformities with a variable presentation. Craniosynostosis may occur in an isolated setting or as part of a syndrome with a variety of inheritance patterns and reccurrence risks. Craniosynostosis occurs in 1/2,200 live births. Availability 4 weeks Gene Set Description Genes in the Craniosynostosis Panel and their clinical significance Gene Associated phenotypes Inheritance ClinVar HGMD ALPL Odontohypophosphatasia, Hypophosphatasia perinatal lethal, AD/AR 78 291 infantile, juvenile and adult forms ALX3 Frontonasal dysplasia type 1 AR 8 8 ALX4 Frontonasal dysplasia type 2, Parietal foramina AD/AR 15 24 BMP4 Microphthalmia, syndromic, Orofacial cleft AD 8 39 CDC45 Meier-Gorlin syndrome 7 AR 10 19 EDNRB Hirschsprung disease, ABCD syndrome, Waardenburg syndrome AD/AR 12 66 EFNB1 Craniofrontonasal dysplasia XL 28 116 ERF Craniosynostosis 4 AD 17 16 ESCO2 SC phocomelia syndrome, Roberts syndrome
    [Show full text]
  • MECHANISMS in ENDOCRINOLOGY: Novel Genetic Causes of Short Stature
    J M Wit and others Genetics of short stature 174:4 R145–R173 Review MECHANISMS IN ENDOCRINOLOGY Novel genetic causes of short stature 1 1 2 2 Jan M Wit , Wilma Oostdijk , Monique Losekoot , Hermine A van Duyvenvoorde , Correspondence Claudia A L Ruivenkamp2 and Sarina G Kant2 should be addressed to J M Wit Departments of 1Paediatrics and 2Clinical Genetics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Email The Netherlands [email protected] Abstract The fast technological development, particularly single nucleotide polymorphism array, array-comparative genomic hybridization, and whole exome sequencing, has led to the discovery of many novel genetic causes of growth failure. In this review we discuss a selection of these, according to a diagnostic classification centred on the epiphyseal growth plate. We successively discuss disorders in hormone signalling, paracrine factors, matrix molecules, intracellular pathways, and fundamental cellular processes, followed by chromosomal aberrations including copy number variants (CNVs) and imprinting disorders associated with short stature. Many novel causes of GH deficiency (GHD) as part of combined pituitary hormone deficiency have been uncovered. The most frequent genetic causes of isolated GHD are GH1 and GHRHR defects, but several novel causes have recently been found, such as GHSR, RNPC3, and IFT172 mutations. Besides well-defined causes of GH insensitivity (GHR, STAT5B, IGFALS, IGF1 defects), disorders of NFkB signalling, STAT3 and IGF2 have recently been discovered. Heterozygous IGF1R defects are a relatively frequent cause of prenatal and postnatal growth retardation. TRHA mutations cause a syndromic form of short stature with elevated T3/T4 ratio. Disorders of signalling of various paracrine factors (FGFs, BMPs, WNTs, PTHrP/IHH, and CNP/NPR2) or genetic defects affecting cartilage extracellular matrix usually cause disproportionate short stature.
    [Show full text]
  • A Novel De Novo 20Q13.32&Ndash;Q13.33
    Journal of Human Genetics (2015) 60, 313–317 & 2015 The Japan Society of Human Genetics All rights reserved 1434-5161/15 www.nature.com/jhg ORIGINAL ARTICLE Anovelde novo 20q13.32–q13.33 deletion in a 2-year-old child with poor growth, feeding difficulties and low bone mass Meena Balasubramanian1, Edward Atack2, Kath Smith2 and Michael James Parker1 Interstitial deletions of the long arm of chromosome 20 are rarely reported in the literature. We report a 2-year-old child with a 2.6 Mb deletion of 20q13.32–q13.33, detected by microarray-based comparative genomic hybridization, who presented with poor growth, feeding difficulties, abnormal subcutaneous fat distribution with the lack of adipose tissue on clinical examination, facial dysmorphism and low bone mass. This report adds to rare publications describing constitutional aberrations of chromosome 20q, and adds further evidence to the fact that deletion of the GNAS complex may not always be associated with an Albright’s hereditary osteodystrophy phenotype as described previously. Journal of Human Genetics (2015) 60, 313–317; doi:10.1038/jhg.2015.22; published online 12 March 2015 INTRODUCTION resuscitation immediately after birth and Apgar scores were 9 and 9 at 1 and Reports of isolated subtelomeric deletions of the long arm of 10 min, respectively, of age. Birth parameters were: weight ~ 1.56 kg (0.4th–2nd chromosome 20 are rare, but a few cases have been reported in the centile), length ~ 40 cm (o0.4th centile) and head circumference ~ 28.2 cm o fi literature over the past 30 years.1–13 Traylor et al.12 provided an ( 0.4th centile).
    [Show full text]
  • Hearing Loss in Waardenburg Syndrome: a Systematic Review
    Clin Genet 2016: 89: 416–425 © 2015 John Wiley & Sons A/S. Printed in Singapore. All rights reserved Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12631 Review Hearing loss in Waardenburg syndrome: a systematic review Song J., Feng Y., Acke F.R., Coucke P., Vleminckx K., Dhooge I.J. Hearing J. Songa,Y.Fenga, F.R. Ackeb, loss in Waardenburg syndrome: a systematic review. P. Couckec,K.Vleminckxc,d Clin Genet 2016: 89: 416–425. © John Wiley & Sons A/S. Published by and I.J. Dhoogeb John Wiley & Sons Ltd, 2015 aDepartment of Otolaryngology, Xiangya Waardenburg syndrome (WS) is a rare genetic disorder characterized by Hospital, Central South University, Changsha, People’s Republic of China, hearing loss (HL) and pigment disturbances of hair, skin and iris. b Classifications exist based on phenotype and genotype. The auditory Department of Otorhinolaryngology, cDepartment of Medical Genetics, Ghent phenotype is inconsistently reported among the different Waardenburg types University/Ghent University Hospital, and causal genes, urging the need for an up-to-date literature overview on Ghent, Belgium, and dDepartment for this particular topic. We performed a systematic review in search for articles Biomedical Molecular Biology, Ghent describing auditory features in WS patients along with the associated University, Ghent, Belgium genotype. Prevalences of HL were calculated and correlated with the different types and genes of WS. Seventy-three articles were included, describing 417 individual patients. HL was found in 71.0% and was Key words: genotype – hearing loss – predominantly bilateral and sensorineural. Prevalence of HL among the inner ear malformation – phenotype – different clinical types significantly differed (WS1: 52.3%, WS2: 91.6%, Waardenburg syndrome WS3: 57.1%, WS4: 83.5%).
    [Show full text]
  • Hereditary Hearing Impairment with Cutaneous Abnormalities
    G C A T T A C G G C A T genes Review Hereditary Hearing Impairment with Cutaneous Abnormalities Tung-Lin Lee 1 , Pei-Hsuan Lin 2,3, Pei-Lung Chen 3,4,5,6 , Jin-Bon Hong 4,7,* and Chen-Chi Wu 2,3,5,8,* 1 Department of Medical Education, National Taiwan University Hospital, Taipei City 100, Taiwan; [email protected] 2 Department of Otolaryngology, National Taiwan University Hospital, Taipei 11556, Taiwan; [email protected] 3 Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei City 100, Taiwan; [email protected] 4 Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine, Taipei City 100, Taiwan 5 Department of Medical Genetics, National Taiwan University Hospital, Taipei 10041, Taiwan 6 Department of Internal Medicine, National Taiwan University Hospital, Taipei 10041, Taiwan 7 Department of Dermatology, National Taiwan University Hospital, Taipei City 100, Taiwan 8 Department of Medical Research, National Taiwan University Biomedical Park Hospital, Hsinchu City 300, Taiwan * Correspondence: [email protected] (J.-B.H.); [email protected] (C.-C.W.) Abstract: Syndromic hereditary hearing impairment (HHI) is a clinically and etiologically diverse condition that has a profound influence on affected individuals and their families. As cutaneous findings are more apparent than hearing-related symptoms to clinicians and, more importantly, to caregivers of affected infants and young individuals, establishing a correlation map of skin manifestations and their underlying genetic causes is key to early identification and diagnosis of syndromic HHI. In this article, we performed a comprehensive PubMed database search on syndromic HHI with cutaneous abnormalities, and reviewed a total of 260 relevant publications.
    [Show full text]
  • Waardenburg Syndrome Expression and Penetrance Myeshia V
    Shelby MV. J Rare Dis Res Treat. (2017) 2(6): 31-40 Journal of www.rarediseasesjournal.com Rare Diseases Research & Treatment Research Article Open Access Waardenburg Syndrome Expression and Penetrance Myeshia V. Shelby* Department of Genetics and Human Genetics, Howard University Graduate School, Howard University, USA Article Info ABSTRACT Article Notes Through a combination of in silico research and reviews of previous work, Received: November 29, 2017 mechanisms by which nonsense-mediated mRNA decay (NMD) affects the Accepted: December 10, 2017 inheritance and expressivity of Waardenburg syndrome is realized. While *Correspondence: expressivity and inheritance both relate to biochemical processes underlying a Dr. Myeshia V. Shelby, gene’s function, this research explores how alternative splicing and premature Department of Genetics and Human Genetics, Howard termination codons (PTC’s) within mRNAs mutated in the disease are either University Graduate School, Howard University, USA; translated into deleterious proteins or decayed to minimize expression of Email: [email protected] altered proteins. Elucidation of splice variants coupled with NMD perpetuating © 2017 Shelby MV. This article is distributed under the terms of the various symptoms and inheritance patterns of this disease represent novel the Creative Commons Attribution 4.0 International License. findings. By investigating nonsense mutations that lie within and outside the NMD boundary of these transcripts we can evaluate the effects of protein Keywords truncation versus minimized protein expression on the variable expressivity Nonsense-Mediated Decay found between Type I and Type III Waardenburg syndrome, PAX3, while Variable Expressivity comparatively evaluating EDN3 and SOX10’s role in inheritance of Type IV Reduced Penetrance Nonsense Mutation subtypes of the disease.
    [Show full text]
  • Waardenburg Syndrome: a Case Study of 2 Patients
    International Journal of Science and Research (IJSR) ISSN (Online): 2319-7064 Index Copernicus Value (2016): 79.57 | Impact Factor (2015): 6.391 Waardenburg Syndrome: A Case Study of 2 Patients Dr Shruti Muddebihal1, Dr Ravindra Banakar2 1Post Graduate in Ophthalmology 2Professor and HOD department of Ophthalmology JJM Medical College Davangere Abstract: Waardenburg syndrome is an autosomal dominant disease with incidence of 1 in 40000 that manifest with pigmentation defects of skin, hair and iris, sensory neural hearing loss and various defects of neural crest derived tissues. Mutations in EDN3, EDNRB, MITF, PAX3, SNAI2 and SOX10 genes. We report two isolated cases of newborn who presented with complaints of vomiting since day one of birth and other symptoms of intestinal obstruction and all clinical features were consistent with Waardeburg syndrome in the form of white forelock in the midline along with heterochromia iridium, bright red fundal reflex with choroidal depigmentation. Exploratory laparotomy in both cases confirmed Hirschprung disease with histopathological examination report. No family history was noted in both cases. Keywords: Waardenburg syndrome, White forelock, Heterochromia iridium, Hirschprung disease. 1. Introduction Gall bladder sludge Bilateral echogenic kidneys Waardenburg syndrome described by Dutch ophthalmologist Dilated and fluid filled small bowel loops Petrus Johannes Waardenburg1. Autosomal dominant Collapsed colon and minimal ascites disease with incidence of 1 in 40000 that manifest with Exploratory laparotomy with jejunostomy and loop pigmentation defects of skin, hair and iris, sensory neural ileostomy for suspected Hirschsprung’s disease with hearing loss and various defects of neural crest derived Waardenburg syndrome was done. 2 tissues . Mutation in EDN3,EDNRB,MITF,PAX3,SNAI2 Biopsies for frozen section from distal jejunum, distal and SOX10 genes involved in formation and development of ileum, caecum, transverse colon & sigmoid colon showed cells such as melanocytes.
    [Show full text]
  • Genes and Diseases
    Genes and Diseases Harvey Ras oncogene Leukemia, chronic myeloid Myotonic dystrophy Retinoblastoma Severe combined immunodeficiency Narcolepsy From NCBI: Tuberous sclerosis Neurofibromatosis http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=gnd Von Hippel-Lindau syndrome Male-Specific Diseases Niemann–Pick disease Alport syndrome Parkinson disease Genes and Disease is a collection of articles that The Digestive System Male pattern baldness Phenylketonuria discuss genes and the diseases that they cause. These Colon cancer Prostate cancer Prader-Willi syndrome genetic disorders are organized by the parts of the Crohn's disease SRY: Sex determination Refsum disease body that they affect. As some diseases affect various Cystic fibrosis Rett syndrome body systems, they appear in more than one chapter. Diabetes, type 1 Muscle and Bone Spinal muscular atrophy Glucose galactose malabsorption Achondroplasia Spinocerebellar ataxia With each genetic disorder, the underlying Pancreatic cancer Amyotrophic lateral sclerosis Tangier disease mutation(s) is discussed, along with clinical features Wilson's disease Charcot–Marie–Tooth syndrome Tay-Sachs disease and links to key websites. You can browse through Zellweger syndrome Cockayne syndrome Tuberous sclerosis the articles online, and you can also download a Diastrophic dysplasia Von Hippel-Lindau syndrome printable file (PDF) of each chapter. Ear, Nose, and Throat Duchenne muscular dystrophy Williams syndrome Deafness Ellis-van Creveld syndrome Wilson's disease From Genes and Disease you can delve into many Neurofibromatosis Fibrodysplasia ossificans progressiva Zellweger syndrome online related resources with free and full access. For Pendred syndrome Marfan syndrome example, you can visit the human genome to see the Myotonic dystrophy Nutritional and Metabolic Diseases location of the genes implicated in each disorder.
    [Show full text]
  • NGS Panels 2020
    NGS Panels 2020 BENEFIT FROM OUR MEDICAL EXPERTISE AND STREAMLINED GENETIC TESTING NGS Panels 2020 Benefit from our Medical Expertise and Streamlined Genetic Testing CENTOGENE is fully committed to bringing the best possible diagnostic solutions to our patients and their families. We always strive to incorporate the latest in-house findings and medical research in our products to improve and ease the diagnostic odyssey of rare disease patients. To reflect the fast-growing knowledge of complex associations of genes with diseases as well as to maximize clinical sensitivity, we have updated and significantly redesigned our Next Generation Sequencing (NGS) gene panels. The gene composition of each panel has been revised to meet the latest gene discoveries as well as to provide the highest clinical validity. Additionally, we have minimized complexity and removed redundancy in the panel portfolio by creating phenotype-directed diagnostic panels, which are the most comprehensive and include all relevant genes necessary for differential diagnosis of syndromes with overlapping phenotype, therefore allowing the diagnosis of diseases that otherwise would be missed. This principle increases the clinical utility, de-risks panel choice, increases cost-effectiveness, and ultimately simplifies the diagnostic process. When choosing one of our NGS panels, feel confident that you will receive high-quality sequencing combined with best data analysis and interpretation, which are documented in comprehensive medical reports. As always, CENTOGENE and our Customer
    [Show full text]
  • Molecular Genetics of Rare Puberty Disorders in Finland and Denmark
    Doctoral Programme in Biomedicine Medicum/Physiology Faculty of Medicine University of Helsinki MOLECULAR GENETICS OF RARE PUBERTY DISORDERS IN FINLAND AND DENMARK Johanna Känsäkoski ACADEMIC DISSERTATION To be publicly discussed, with the permission of the Faculty of Medicine of the University of Helsinki, in Auditorium XIV, Main Building of the University of Helsinki, Unioninkatu 34, on August 18th 2017, at 12 o’clock noon Helsinki 2017 Supervised by Professor Taneli Raivio, MD, PhD Physiology, Faculty of Medicine University of Helsinki and Children's Hospital Helsinki University Hospital Helsinki, Finland and Docent Johanna Tommiska, PhD Physiology, Faculty of Medicine University of Helsinki and Children's Hospital Helsinki University Hospital Helsinki, Finland Reviewed by Docent Hannele Laivuori, MD, PhD Department of Medical and Clinical Genetics University of Helsinki and Helsinki University Hospital and Institute for Molecular Medicine Finland / HiLIFE University of Helsinki Helsinki, Finland and Docent Kirsti Näntö-Salonen, MD, PhD Department of Pediatrics Turku University Hospital and University of Turku Turku, Finland Official opponent Professor Helena Kääriäinen, MD, PhD National Institute for Health and Welfare and Department of Clinical Genetics Helsinki University Hospital Helsinki, Finland ISBN 978-951-51-3532-2 (paperback) ISBN 978-951-51-3533-9 (PDF) http://ethesis.helsinki.fi Unigrafia Oy Helsinki 2017 Table of Contents LIST OF ORIGINAL PUBLICATIONS .......................................................................
    [Show full text]
  • Disorders of Sex Development Panel
    Abnormal Genitalia/ Disorders of Sex Development Panel Test code: EN0201 Is a 62 gene panel that includes assessment of non-coding variants. Is ideal for patients presenting with ambiguous genitalia, patients suspected to have a disorder of sexual development and patients suspected to have congenital adrenal hyperplasia (CAH). About Abnormal Genitalia/ Disorders of Sex Development Disorders of sex development (DSD) are a group of congenital conditions characterized by problems in the course of gender patterning, gonadal and sex development. It has been estimated that 1% – 2% of live births have some aspect of DSD. Approximately 5% of infants with DSD have ambiguous genitalia and indeterminate sex at birth. However, the vast majority of these patients do not require corrective surgery. Patients with 46,XY DSD have often impaired androgen synthesis or action and may have normal female external genitalia, while patients with 46,XX DSD conditions have often androgen excess. In 46,XX females, congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency (21-OHD) is the most common cause of DSD. The estimated prevalence of CAH is 1:10,000 and 90%-95% of cases are due to mutations in CYP21A2. The severity of the condition often depends on the residual enzyme activity subdiving CYP21A2 mutations in severe (classic phenotype, enzyme activity 0%-10%) and mild (non-classic, enzyme activity 20%-50%). Androgen insensitivity syndrome (AIS), caused by mutations in AR, is characterized by feminization of external genitalia and atypical sexual development in 46,XY individuals. The condition may be complete, partial or mild, depending on the level of androgen insensitivity.
    [Show full text]
  • EUROCAT Syndrome Guide
    JRC - Central Registry european surveillance of congenital anomalies EUROCAT Syndrome Guide Definition and Coding of Syndromes Version July 2017 Revised in 2016 by Ingeborg Barisic, approved by the Coding & Classification Committee in 2017: Ester Garne, Diana Wellesley, David Tucker, Jorieke Bergman and Ingeborg Barisic Revised 2008 by Ingeborg Barisic, Helen Dolk and Ester Garne and discussed and approved by the Coding & Classification Committee 2008: Elisa Calzolari, Diana Wellesley, David Tucker, Ingeborg Barisic, Ester Garne The list of syndromes contained in the previous EUROCAT “Guide to the Coding of Eponyms and Syndromes” (Josephine Weatherall, 1979) was revised by Ingeborg Barisic, Helen Dolk, Ester Garne, Claude Stoll and Diana Wellesley at a meeting in London in November 2003. Approved by the members EUROCAT Coding & Classification Committee 2004: Ingeborg Barisic, Elisa Calzolari, Ester Garne, Annukka Ritvanen, Claude Stoll, Diana Wellesley 1 TABLE OF CONTENTS Introduction and Definitions 6 Coding Notes and Explanation of Guide 10 List of conditions to be coded in the syndrome field 13 List of conditions which should not be coded as syndromes 14 Syndromes – monogenic or unknown etiology Aarskog syndrome 18 Acrocephalopolysyndactyly (all types) 19 Alagille syndrome 20 Alport syndrome 21 Angelman syndrome 22 Aniridia-Wilms tumor syndrome, WAGR 23 Apert syndrome 24 Bardet-Biedl syndrome 25 Beckwith-Wiedemann syndrome (EMG syndrome) 26 Blepharophimosis-ptosis syndrome 28 Branchiootorenal syndrome (Melnick-Fraser syndrome) 29 CHARGE
    [Show full text]